Results 111 to 120 of about 4,270,323 (214)
This nationwide survey reveals that comprehensive multigene testing for advanced NSCLC has rapidly expanded in Japan, steadily increasing the use of targeted therapies for rare oncogenic drivers. Despite these diagnostic advancements, approximately 30% of patients consistently remain untested, highlighting a persistent clinical gap in real‐world ...
Satoshi Ikeda +9 more
wiley +1 more source
Innovations in cancer immunotherapy have resulted in the development of several novel immunotherapeutic strategies that can disrupt immunosuppression. One key advancement lies in immune checkpoint inhibitors (ICIs), which have shown significant clinical ...
Mai Ho, Benjamin Bonavida
doaj +1 more source
Nationwide real‐world profiling revealed distinct clinicogenomic contexts across major BRAF alteration classes in gliomas and glioneuronal tumors. KIAA1549::BRAF fusion was associated with younger age and predominantly low‐grade tumors, whereas BRAF amplification‐only tumors were predominantly high‐grade and showed frequent MET amplification.
Seiji Yamada +7 more
wiley +1 more source
CD36‐mediated lipid rewiring in the metabolic adaptation of tumour ecosystems
Nutrient deprivation drives a lipid‐centric shift in tumour metabolic symbiosis and signalling network. CD36 functions as a bidirectional bridge, transferring fatty acids from stromal donors (adipocytes, CAFs) to the ecosystem tumour‐ and microenvironment‐dependently.
Anna Sebestyén +11 more
wiley +1 more source
FTO regulates mRNA stability and translational efficiency through its m6A‐demethylation activity. GSK3 functions as an upstream regulator of FTO, leading to its inhibition via phosphorylation. In male germ cells, FTO activity is kept in check by GSK3α.
Neha Choudhari +7 more
wiley +1 more source
Lung adenocarcinoma (LUAD), the most common subtype of non‐small‐cell lung cancer (NSCLC), is often driven by mutations, particularly in epidermal growth factor receptor (EGFR), that guide targeted therapy choices. However, resistance to these treatments
Ana Raquel‐Cunha +10 more
doaj +1 more source
Structural features of ZAK kinase regulation at the ribosome
ZAK kinase binds ribosomes in various states (hibernating, translating, and colliding). Widespread ribosome collisions promote ZAK autophosphorylation and activation of the ribotoxic stress response pathway. This stress signaling pathway mediates downstream cell fate decisions such as cell cycle arrest and apoptosis. ZAKα is a MAP3K that interacts with
Shuangshuang Niu +3 more
wiley +1 more source
Background: Recent advances in the treatment of melanoma that involve immunotherapy and B-Raf inhibition have revolutionised cancer care for this disease.
Bruce H. Littman +14 more
core +1 more source
Host genetic variation in immune regulation and cell signalling genes was associated with microbiome composition across vaginal, gut, oral and skin sites, while associations involving metabolic function, epithelial barrier integrity and hormonal processes were more site‐specific. Overall, our findings indicate that host genetic variation contributes to
Isabella Margaret Davidson +4 more
wiley +1 more source
Phosphotyrosine recognition by raf kinase inhibitor protein
Raf kinase inhibitor protein (RKIP) negatively regulates the mitogen-activated protein kinase (MAPK) signaling cascade by direct interaction with Raf-1.
Simister, PC, Burton, NM, Brady, RL
core

